Dr. Jeroen J.W.M. Janssen  - CML - Chronic myeloid leukemia

Department of Hematology, VU University medical center, Amsterdam, Netherlands
​
VUmc Cancer Center Amsterdam (CCA) is a national and international leading center for cancer research and treatment 
​​

VIDEOS

Stap in de wereld van VUmc Cancer Center Amsterdam
May 31, 2016, VUmc Amsterdam
​​

ARTICLES

Ponatinib in chronic myeloid leukemia (CML): Consensus on patient treatment and management from a European expert panel
December 2017, ScienceDirect
 
Impact of hospital experience on the quality of tyrosine kinase inhibitor response monitoring and consequence for chronic myeloid leukemia patient survival
August 31, 2017, European Hematology Association